PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study
暂无分享,去创建一个
J. Denollet | J. Spertus | M. Shishehbor | J. Abbott | J. Beltrame | J. Heyligers | P. Vriens | A. Hirsch | H. Aronow | K. Smolderen | Kensey L. Gosch | R. Fitridge | C. Labrosciano | M. Patel | W. S. Jones | Nancy Stone MEd | Rudolf Tutein-Nolthenius | John A Spertus | MEd Nancy Stone | Mehdi H Shishehbor | W. S. Jones | Alan T. Hirsch | Robert Fitridge | Nancy Stone, MEd | J. D. Abbott | John A. Spertus
[1] Mark D. Huffman,et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.
[2] S. Goldhaber,et al. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. , 2013, American heart journal.
[3] Eric E. Smith,et al. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standar , 2012, Circulation.
[4] J. Spertus,et al. Medication Discussion Questions (MedDQ): Developing a Guide to Facilitate Patient-Clinician Communication About Heart Medications , 2011, The Journal of cardiovascular nursing.
[5] Ryan J. Mays,et al. Assessment of functional status and quality of life in claudication. , 2011, Journal of vascular surgery.
[6] Elizabeth DeLong,et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I , 2010, Journal of the American College of Cardiology.
[7] R. Bonow,et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and I , 2010, Circulation.
[8] A. O'Connor,et al. Are you SURE?: Assessing patient decisional conflict with a 4-item screening test. , 2010, Canadian family physician Medecin de famille canadien.
[9] D. Pittrow,et al. Management of patients with peripheral arterial disease in primary care: a cross‐sectional study in Germany , 2010, International journal of clinical practice.
[10] V. Aboyans,et al. Characteristics and outcome of patients hospitalised for lower extremity peripheral artery disease in France: the COPART Registry. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[11] J. Denollet,et al. Impact of peripheral arterial disease on health status: a comparison with chronic heart failure. , 2009, Journal of vascular surgery.
[12] T. Strine,et al. The PHQ-8 as a measure of current depression in the general population. , 2009, Journal of affective disorders.
[13] M. Criqui,et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program , 2008, Vascular medicine.
[14] H. Krumholz,et al. Financial barriers to health care and outcomes after acute myocardial infarction. , 2007, JAMA.
[15] M. Chiariello,et al. Mortality in Peripheral Arterial Disease: A Comparison of Patients Managed by Vascular Specialists and General Practitioners , 2007, Journal of General Internal Medicine.
[16] J. Spertus,et al. Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization , 2007, Circulation.
[17] J. Blacher,et al. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study. , 2006, Journal of vascular surgery.
[18] C. Kalbaugh,et al. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. , 2006, Journal of vascular surgery.
[19] B. Löwe,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.
[20] Rodney A. White,et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.
[21] Johan Denollet,et al. DS14: Standard Assessment of Negative Affectivity, Social Inhibition, and Type D Personality , 2005, Psychosomatic medicine.
[22] J. Dumville,et al. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.
[23] J. Spertus,et al. The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. , 2004, American heart journal.
[24] Gail Ironson,et al. A short social support measure for patients recovering from myocardial infarction: the ENRICHD Social Support Inventory. , 2003, Journal of cardiopulmonary rehabilitation.
[25] M. Suarez‐Almazor,et al. The prevalence of peripheral arterial disease in a racially diverse population. , 2003, Archives of internal medicine.
[26] L. Holmberg,et al. Areas of concern, quality of life and life satisfaction in patients with peripheral vascular disease. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[27] R. Spitzer,et al. The PHQ-9 , 2001, Journal of General Internal Medicine.
[28] R. Rabin,et al. EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.
[29] L. Fried,et al. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. , 2000, Circulation.
[30] R. Spitzer,et al. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.
[31] P. Greenland,et al. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. , 1999, Archives of internal medicine.
[32] D. Bloch,et al. A simple method of sample size calculation for linear and logistic regression. , 1998, Statistics in medicine.
[33] R. Deber,et al. What role do patients wish to play in treatment decision making? , 1996, Archives of internal medicine.
[34] F. Fowkes,et al. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. , 1992, Journal of clinical epidemiology.
[35] F. Fowkes,et al. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. , 1988, International journal of epidemiology.
[36] T. Kamarck,et al. A global measure of perceived stress. , 1983, Journal of health and social behavior.
[37] J. Cigarroa,et al. Correction to: 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Circulation.
[38] R. Spitzer,et al. The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.
[39] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .